Papayannakos Christopher J, Israr Mohd, DeVoti James A, Lam Fung, Arazi Arnon, Frank Douglas K, Kamdar Dev P, Pereira Lucio M, Seetharamu Nagashree, Steinberg Bettie M, Bonagura Vincent R
Northwell, New Hyde Park, NY, United States.
Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States.
Front Immunol. 2025 Mar 19;16:1539780. doi: 10.3389/fimmu.2025.1539780. eCollection 2025.
Tumor-associated macrophages (TAMs) recruited from circulating monocytes drive tumor-growth and establish an immunosuppressive tumor microenvironment (TME). Initial events in transition from resting monocytes to TAMs are poorly understood. Here, we report that monocytes from oropharyngeal cancer (OPC) patients and control monocytes treated with OPC-conditioned media (CM) express a repertoire of pro-tumor mediators that is characteristic of TAMs.
Monocytes were stimulated with OPC cell line CM, analyzed by single-cell RNAseq. Results of select genes were confirmed by qPCR with monocytes and analyzed in OPC tumors vs. clinically normal tissue. OPC spheroids containing control monocytes and T-cells were established, TAM phenotype characterized by flow analysis and qPCR, and T-cell proliferation assessed by flow.
OPC-conditioned media induced multiple pro-tumor genes including , and . Patient monocytes had higher baseline levels or achieved higher levels after stimulation than control monocytes. A subset of patient monocytes had high baseline levels of expression that resisted downregulation in response to stimulation, a potential sign of a more favorable TME. expression in OPC tumor biopsies compared to clinically normal tissue correlated with patient outcome. Spheroid TAMs derived from control monocytes maintained the pro-tumor repertoire seen with monocytes stimulated by tumor line conditioned media. These TAMs suppress T-cell proliferation. Inhibition of COX-2 or IL1 signaling during differentiation into TAMs partially blocked the suppression of T-cell proliferation.
Targeting the early transition of monocytes into pro-tumor TAMs could be used to develop new therapies for OPC.
从循环单核细胞招募而来的肿瘤相关巨噬细胞(TAM)驱动肿瘤生长并建立免疫抑制性肿瘤微环境(TME)。从静息单核细胞转变为TAM的初始事件目前了解甚少。在此,我们报告,来自口咽癌(OPC)患者的单核细胞以及用OPC条件培养基(CM)处理的对照单核细胞表达了一系列TAM特有的促肿瘤介质。
用OPC细胞系CM刺激单核细胞,通过单细胞RNA测序进行分析。选择基因的结果通过对单核细胞进行qPCR得到确认,并在OPC肿瘤与临床正常组织中进行分析。建立含有对照单核细胞和T细胞的OPC球体,通过流式分析和qPCR对TAM表型进行表征,并通过流式评估T细胞增殖。
OPC条件培养基诱导了多个促肿瘤基因,包括 、 和 。患者单核细胞的基线水平较高,或在刺激后达到比对照单核细胞更高的水平。一部分患者单核细胞具有较高的基线 表达水平,在受到刺激后抵抗下调,这可能是更有利的TME的一个迹象。与临床正常组织相比,OPC肿瘤活检中的 表达与患者预后相关。源自对照单核细胞的球体TAM维持了与肿瘤细胞系条件培养基刺激的单核细胞所见相同的促肿瘤特征。这些TAM抑制T细胞增殖。在分化为TAM的过程中抑制COX-2或IL1信号传导可部分阻断对T细胞增殖的抑制。
靶向单核细胞向促肿瘤TAM的早期转变可用于开发OPC的新疗法。